These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3494623)

  • 1. The selective activation of T8+ cells by neuraminidase and galactose oxidase is mediated by activated T4+ cells.
    Akeson AL; Harmony JA
    Exp Cell Res; 1987 May; 170(1):129-46. PubMed ID: 3494623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
    Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
    J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphatidylinositol response and proliferation of oxidative enzyme-activated human T lymphocytes: suppression by plasma lipoproteins.
    Akeson AL; Scupham DW; Harmony JA
    J Lipid Res; 1984 Nov; 25(11):1195-205. PubMed ID: 6335165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic properties of neuraminidase and galactose oxidase-treated lymphoblastoid cells and plasma membranes for peripheral blood lymphocytes.
    Arnold A; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Nov; 133(5):2569-76. PubMed ID: 6332856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC; Henney CS
    J Immunol; 1977 Dec; 119(6):2163-71. PubMed ID: 303259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation by low-density lipoproteins of the activation of oxidative enzyme-primed lymphocytes is governed by transferrin.
    Scupham DW; McCarthy BM; Harmony JA
    Cell Immunol; 1987 Sep; 108(2):378-95. PubMed ID: 3497727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of supernatants from neuraminidase and galactose oxidase (NAGO)-treated lymphocytes as a source of T cell growth factor.
    Berzins T; Wikén M; Hellström U; Perlmann P
    J Immunol Methods; 1983 Oct; 63(3):309-19. PubMed ID: 6605390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessory cell-independent activation of T cells by oxidized red blood cells plus polyethylene glycol.
    Ocklind G; Lindahl-Kiessling K
    Immunobiology; 1987 Dec; 176(1-2):167-76. PubMed ID: 3502338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.
    Novogrodsky A; Suthanthiran M; Saltz B; Newman D; Rubin AL; Stenzel KH
    J Exp Med; 1980 Mar; 151(3):755-60. PubMed ID: 7359085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.
    Suthanthiran M; Rubin AL; Novogrodsky A; Stenzel KH
    Transplantation; 1980 Oct; 30(4):269-74. PubMed ID: 6255637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and growth factor requirements for the direct and indirect oxidative induction of interleukin 2 responsiveness in human thymocytes.
    Roffman E; Vidne BA; Wilchek M
    Immunol Lett; 1985; 9(2-3):131-7. PubMed ID: 3921457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of oxidative mitogenesis does not correlate with the degree of aldehyde formation of the T lymphocyte membrane.
    Roffman E; Wilchek M
    J Immunol; 1986 Jul; 137(1):40-4. PubMed ID: 3086457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
    Phillips ML; Wettstein PJ; O'Brien RL; Parker JW; Frelinger JA
    J Immunol; 1980 Jun; 124(6):2693-9. PubMed ID: 6246169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative pathway induction of T lymphocyte mitogen stimulation.
    Peters JH; Schimmelpfeng L
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):169-82. PubMed ID: 218373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of memory cells by chemical modification of the lymphocyte cell surface.
    Stenzel KH; Suthanthiran M; Rubin AL; Novogrodsky A
    Proc Eur Dial Transplant Assoc; 1979; 16():437-41. PubMed ID: 162003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the induction and expression of T cell-mediated immunity. IX. Activation of alloimmune memory lymphocytes into specific secondary CTL by syngeneic NAGO-oxidized stimulator cells.
    Grimm EA; Bonavida B
    J Immunol; 1979 Nov; 123(5):2026-33. PubMed ID: 314955
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory interactions governing the proliferation of T cell subsets stimulated with pokeweed mitogen.
    Puck JM; Rich RR
    J Immunol; 1984 Mar; 132(3):1106-12. PubMed ID: 6229576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and surface phenotype of human T lymphocytes producing interleukin 2. Analysis by limiting dilution and cell cloning.
    Moretta A
    Eur J Immunol; 1985 Feb; 15(2):148-55. PubMed ID: 3871697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of neuraminidase and galactose oxidase on murine lymphocytes. II. Induction of T suppressor cells.
    Kuppers RC; Henney CS
    J Immunol; 1979 May; 122(5):1834-41. PubMed ID: 312852
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.